Phase 1 Peripheral neuropathic pain Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Cannabidiol for the Treatment of Diabetic Peripheral Neuropathy: Pilot Study

Diabetic NeuropathiesDiabetic Peripheral Neuropathic Pain (DPN)

Florida A&M University20 enrolled1 locationNCT07298408

Completed

Phase 1

A Phase 1, Randomized, Double-Blind, Placebo-Controlled Single and Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of STC-004

Chronic, peripheral neuropathic pain

SiteOne Therapeutics76 enrolled1 locationACTRN12624000642583

Completed

Phase 1

Study of ZYN001 (transdermal patch) in Healthy Volunteers

Peripheral neuropathic painFibromyalgia

Zynerba Pharmaceuticals Pty. Ltd20 enrolled1 locationACTRN12617001028392